Systemic immune inflammation index and all-cause mortality in chronic kidney disease: A prospective cohort study

被引:1
|
作者
Jia, Meng [1 ]
Yuan, Wenli [1 ]
Chen, Yinqing [1 ]
Wang, Yi [1 ]
Shang, Li [2 ]
Han, Shisheng [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western M, Dept Nephrol, Shanghai, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Inst Sci Technol & Humanities, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
all-cause mortality; chronic kidney disease; cohort study; NHANES; systemic immune inflammation index; PLATELET ACTIVATION; OUTCOMES; CKD; ASSOCIATION; RISKS;
D O I
10.1002/iid3.1358
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundThe aim of this study was to investigate the association between systemic immune-inflammation index (SII) and all-cause mortality in individuals with chronic kidney disease (CKD).Patients and MethodsThis prospective cohort study was carried out among 9303 participants with CKD from the National Health and Nutrition Examination Survey cycles spanning 1999 to 2018. The mortality data were ascertained by linking participant records to the National Death Index up to December 31, 2019. Complex sampling-weighted multivariate Cox proportional hazards models were employed to estimate the association between SII level and all-cause mortality, providing hazard ratios (HR) and 95% confidence intervals (CI). A restricted cubic spline analysis was conducted to explore potential nonlinear correlation. Subgroup analyses and sensitivity analyses were also conducted.ResultsDuring a median follow-up period of 86 months, 3400 (36.54%) all-cause deaths were documented. A distinctive "J"-shaped relationship between SII level and all-cause mortality was discerned among individuals with CKD, with the nadir observed at an SII level of 478.93 within the second quartile. After adjusting for potential covariates, the risk of all-cause mortality escalated by 13% per increment of one standard deviation of SII, once SII exceeded 478.93 (HR = 1.13; 95% CI = 1.08-1.18). An elevated SII was associated with an increased risk of all-cause mortality among patients with CKD (Q4 vs. Q2: HR = 1.23; 95% CI = 1.01-1.48). Subgroup analyses indicated that the correlation between SII and CKD mortality was particularly pronounced among participants over 60 years old and individuals with diabetes. Sensitivity analyses revealed a linear positive association between SII and all-cause mortality after removing the extreme 5% outliers of SII.ConclusionsA distinctive "J"-shaped relationship between SII level and all-cause mortality was identified among individuals with CKD. Further research is warranted to validate and expand upon these findings. This study aimed to investigate the association between systemic immune-inflammation index (SII) and all-cause mortality in individuals with chronic kidney disease (CKD). A distinctive "J"-shaped relationship between SII level and all-cause mortality was identified among individuals with CKD.image
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Association of Systemic Immune Inflammation Index with All-Cause, Cardiovascular Disease, and Cancer-Related Mortality in Patients with Cardiovascular Disease: A Cross-Sectional Study
    Xiao, Shengjue
    Wang, Zhenwei
    Zuo, Ronghua
    Zhou, Yufei
    Yang, Yiqing
    Chen, Tian
    Liu, Naifeng
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 941 - 961
  • [42] Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study
    Giuseppe Penno
    Anna Solini
    Emanuela Orsi
    Enzo Bonora
    Cecilia Fondelli
    Roberto Trevisan
    Monica Vedovato
    Franco Cavalot
    Gianpaolo Zerbini
    Olga Lamacchia
    Antonio Nicolucci
    Giuseppe Pugliese
    BMC Medicine, 19
  • [43] Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study
    Penno, Giuseppe
    Solini, Anna
    Orsi, Emanuela
    Bonora, Enzo
    Fondelli, Cecilia
    Trevisan, Roberto
    Vedovato, Monica
    Cavalot, Franco
    Zerbini, Gianpaolo
    Lamacchia, Olga
    Nicolucci, Antonio
    Pugliese, Giuseppe
    BMC MEDICINE, 2021, 19 (01)
  • [44] Association of dietary isoflavones intake with all-cause mortality and heart disease mortality: a prospective cohort study
    Yan, Yifei
    Qiu, Mingning
    Li, Jianchang
    BMC PUBLIC HEALTH, 2025, 25 (01)
  • [45] ALL-CAUSE MORTALITY IN A SYSTEMIC LUPUS ERYTHEMATOSUS COHORT
    Petri, M. A.
    Levy, J.
    Sbarigia, U.
    Goldman, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1107 - 1108
  • [46] Blood Pressure and Risk of All-Cause Mortality in Advanced Chronic Kidney Disease and Hemodialysis The Chronic Renal Insufficiency Cohort Study
    Bansal, Nisha
    McCulloch, Charles E.
    Rahman, Mahboob
    Kusek, John W.
    Anderson, Amanda H.
    Xie, Dawei
    Townsend, Raymond R.
    Lora, Claudia M.
    Wright, Jackson
    Go, Alan S.
    Ojo, Akinlolu
    Alper, Arnold
    Lustigova, Eva
    Cuevas, Magda
    Kallem, Radhakrishna
    Hsu, Chi-Yuan
    HYPERTENSION, 2015, 65 (01) : 93 - +
  • [47] The systemic immune-inflammation index was non-linear associated with all-cause mortality in individuals with nonalcoholic fatty liver disease
    Zhao, Enfa
    Cheng, Yiping
    Yu, Chunxiao
    Li, Huijie
    Fan, Xiude
    ANNALS OF MEDICINE, 2023, 55 (01)
  • [48] All-Cause Mortality in a Systemic Lupus Erythematosus Cohort
    Petri, Michelle
    Levy, Joseph
    Sbarigia, Urbano
    Goldman, Daniel W.
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4081 - 4083
  • [49] Serum metabolites are associated with all-cause mortality in chronic kidney disease
    Hu, Jiun-Ruey
    Coresh, Josef
    Inker, Lesley A.
    Levey, Andrew S.
    Zheng, Zihe
    Rebholz, Casey M.
    Tin, Adrienne
    Appel, Lawrence J.
    Chen, Jingsha
    Sarnak, Mark J.
    Grams, Morgan E.
    KIDNEY INTERNATIONAL, 2018, 94 (02) : 381 - 389
  • [50] Yoga participation and all-cause mortality: National prospective cohort study
    Loprinzi, Paul D.
    COMPLEMENTARY THERAPIES IN MEDICINE, 2015, 23 (06) : 757 - 758